Human Microbiome Market, By Product (Prebiotics, Drugs, and Synbiotics), By Diseases, By Type, By Route of Administration, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4099
|
Published Date
July 2025
|
Pages
260
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Human microbiome market size was valued at US$ 821.90 Million in 2024, expanding at a CAGR of 31.20% from 2025 to 2032.
The human microbiome encompasses the vast and diverse community of microorganisms—such as bacteria, viruses, fungi, and other microbes—that reside in different parts of the body, including the gut, skin, mouth, and respiratory tract. These microorganisms are essential for maintaining overall health, playing key roles in digestion, immune system support, and protection against harmful pathogens. An imbalance or disruption in the microbiome has been associated with a range of health conditions, including obesity, diabetes, and autoimmune disorders.
Human Microbiome Market- Market Dynamics
Rising Prevalence of Chronic Diseases to Drive Market Growth
The rising prevalence of chronic conditions such as obesity, diabetes, and inflammatory bowel disease (IBD) is significantly driving demand for microbiome-based therapies. According to the World Obesity Atlas 2023, approximately 38% of the global population—equivalent to 3.12 billion people—are classified as overweight or obese. In parallel, increased government funding and investment in microbiome research are accelerating scientific advancements, further fueling the growth of the global human microbiome market. However, the market faces notable challenges. The high cost of research and development (R&D) and stringent regulatory frameworks may hinder growth over the forecast period. Despite these obstacles, the rising focus on personalized healthcare presents significant opportunities. Microbiome-based diagnostics and therapies tailored to individual microbiota profiles are expected to play a key role in the future of precision medicine.
Human Microbiome Market- Segmentation Analysis:
The Global Human Microbiome Market is segmented on the basis of Product, Diseases, Type, Route of Administration, End-user, and Region.
The human microbiome market is segmented into four product categories: prebiotics, probiotics, drugs, and synbiotics. Among these, the probiotics segment is anticipated to hold the largest market share during the forecast period. This dominance is primarily driven by rising consumer awareness regarding the health benefits of probiotics, particularly in improving gut health, enhancing immune function, and promoting overall wellness. Government initiatives to promote dietary supplements and preventive healthcare have supported this trend. For instance, the U.S. Food and Drug Administration (FDA) continues to regulate and provide guidance on the use of probiotics in food and supplements, recognizing their growing role in preventive medicine and public health.
In terms of disease type, the market is divided into gastrointestinal diseases, infectious diseases, endocrine & metabolic disorders, and other conditions. The gastrointestinal diseases segment is expected to dominate the market, owing to the high global prevalence of digestive disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), celiac disease, and gastroesophageal reflux disease (GERD). According to the World Gastroenterology Organisation, over 10–15% of the global population suffers from IBS, and inflammatory bowel conditions are on the rise in both developed and emerging markets. These statistics underline the growing need for microbiome-targeted therapies, especially in managing complex and chronic digestive conditions with fewer side effects.
Human Microbiome Market- Geographical Insights
Geographically, North America holds the largest share of the global human microbiome market. This dominance is attributed to a well-developed healthcare infrastructure, high levels of investment in microbiome research, and the rising prevalence of chronic diseases such as diabetes, obesity, and gastrointestinal disorders. The U.S. National Institutes of Health (NIH) launched the Human Microbiome Project, investing over $215 million to advance research and commercial applications related to human microbiota. This has significantly boosted innovation and product development in the region.
The Asia-Pacific region is projected to experience the fastest growth in the human microbiome market during the forecast period. This rapid expansion is driven by growing public and clinical awareness of microbiome health, increasing adoption of personalized medicine, and technological advancements in genetic sequencing. Governments in countries like India and China are promoting biotechnology and pharmaceutical innovation. For example, India’s Department of Biotechnology has launched programs under the \"National Biopharma Mission\" to support microbiome-based research and product development, aiming to position the country as a global hub for biotherapeutics. Similarly, China\'s 14th Five-Year Plan emphasizes precision health and includes substantial funding for microbiome and genetic research, further fueling regional market growth.
Human Microbiome Market- Competitive Landscape:
The growing interest in personalized medicine and microbiome-based therapies is intensifying competition among companies in this emerging sector. Industry players are prioritizing strategic collaborations with research institutions and healthcare providers to accelerate the development of innovative products. Significant investments in research and development (R&D) are being made to discover novel microbiome-based diagnostics and therapeutics.
To strengthen their product pipelines, many companies are actively securing patents and entering into licensing agreements. Additionally, expansion into untapped geographic markets and the creation of consumer-focused microbiome products are key competitive strategies driving market growth.
Recent Developments
- In February 2025, Seres Therapeutics launched SER-109, the first FDA-approved microbiome therapy in the U.S. This groundbreaking treatment targets recurrent Clostridioides difficile infection by restoring gut microbiota through the use of live bacterial spores.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HUMAN MICROBIOME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- ENTEROME
- Pendulum
- DuPont
- Yakult U.S.A. Inc.
- Metabiomics
- Vedanta Biosciences, Inc.
- Optibiotix Health plc
- Microbiome Therapeutics Innovation Group
- BioHM Health
- Osel, Inc.
- Seres Therapeutics
- Infinant Health Inc.
- Merck & Co., Inc.
- Theriva Biologics
- Qualigen Therapeutics, Inc.
- Synlogic
- Symbiotix, LLC
- Resbiotic
- Symberix, Inc.
- Exegi Pharma Inc.
- Seed Health Inc.
- Biogaia AB
- BiomeBank
- Ferring Pharmaceuticals
- Others
GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Prebiotics
- Drugs
- Synbiotics
GLOBAL HUMAN MICROBIOME MARKET, BY DISEASES- MARKET ANALYSIS, 2019 - 2032
- Gastrointestinal Diseases
- Infectious Diseases
- Endocrine & Metabolic Disorders
- Other Diseases
GLOBAL HUMAN MICROBIOME MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Live Biotherapeutic Products (LBP)
- Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
- Other Microbiome Types
GLOBAL HUMAN MICROBIOME MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
- Rectal
- Oral
GLOBAL HUMAN MICROBIOME MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Long-term Care Facilities
- Hospitals & Clinics
- Others
GLOBAL HUMAN MICROBIOME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Human Microbiome Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Human Microbiome Market Snippet by Product
2.1.2. Human Microbiome Market Snippet by Diseases
2.1.3. Human Microbiome Market Snippet by Type
2.1.4. Human Microbiome Market Snippet by Route of Administration
2.1.5. Human Microbiome Market Snippet by End User
2.1.6. Human Microbiome Market Snippet by Country
2.1.7. Human Microbiome Market Snippet by Region
2.2. Competitive Insights
3. Human Microbiome Key Market Trends
3.1. Human Microbiome Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Human Microbiome Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Human Microbiome Market Opportunities
3.4. Human Microbiome Market Future Trends
4. Human Microbiome Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Human Microbiome Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Human Microbiome Market Landscape
6.1. Human Microbiome Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Human Microbiome Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Probiotics
7.1.3. Drugs
7.1.4. Synbiotics
8. Human Microbiome Market – By Diseases
8.1. Overview
8.1.1. Segment Share Analysis, By Diseases, 2024 & 2032 (%)
8.1.2. Gastrointestinal Diseases
8.1.3. Infectious Diseases
8.1.4. Endocrine & Metabolic Disorders
8.1.5. Other Diseases
9. Human Microbiome Market – By Type
9.1. Overview
9.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
9.1.2. Live Biotherapeutic Products (LBP)
9.1.3. Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
9.1.4. Other Microbiome Types
10. Human Microbiome Market – By Route of Administration
10.1. Overview
10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
10.1.2. Rectal
10.1.3. Oral
11. Human Microbiome Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Long-term Care Facilities
11.1.3. Hospitals & Clinics
11.1.4. Others
12. Human Microbiome Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Human Microbiome Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Human Microbiome Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Human Microbiome Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Human Microbiome Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Human Microbiome Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Human Microbiome Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. ENTEROME
13.2.2. Pendulum
13.2.3. DuPont
13.2.4. Yakult U.S.A. Inc.
13.2.5. Metabiomics
13.2.6. Vedanta Biosciences, Inc.
13.2.7. Optibiotix Health plc
13.2.8. Microbiome Therapeutics Innovation Group
13.2.9. BioHM Health
13.2.10. Osel, Inc.
13.2.11. Seres Therapeutics
13.2.12. Infinant Health Inc.
13.2.13. Merck & Co., Inc.
13.2.14. Theriva Biologics
13.2.15. Qualigen Therapeutics, Inc.
13.2.16. Synlogic
13.2.17. Symbiotix, LLC
13.2.18. Resbiotic
13.2.19. Symberix, Inc.
13.2.20. Exegi Pharma Inc.
13.2.21. Seed Health Inc.
13.2.22. Biogaia AB
13.2.23. BiomeBank
13.2.24. Ferring Pharmaceuticals
13.2.25. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
